FastWave Medical, a developer in advanced intravascular lithotripsy (IVL) technology, announced the issuance of its sixth utility patent by the United States Patent and Trademark Office (USPTO). This ...
Feasibility study for coronary artery disease will commence ahead of FastWave's expected U.S. pivotal trial. "FastWave's laser IVL system is sophisticated, yet very easy to use. It holds a lot of ...
Abbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...
Findings demonstrate safety, procedural success, and imaging-confirmed calcium modification using a next-generation laser intravascular lithotripsy (IVL) platform. MINNEAPOLIS, Oct. 29, 2025 ...
BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular ...
LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within coronary artery plaques MY-IVL study enrolled 102 real ...
Johnson & Johnson’s Shockwave Medical strengthened its position in the intravascular lithotripsy (IVL) market. The New Brunswick, NJ-based company said earlier this week that it was launching the ...
Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results